new oral cancer drugs, Nexavar and Sutent

You'll see two new oral cancer drugs, Nexavar and Sutent.

These drugs work similarly to Gleevec (imatinib). They block proteins involved in a tumor's growth and blood supply.

But Nexavar and Sutent target a wider range of proteins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote